Clearstead Advisors, LLC Veracyte, Inc. Transaction History

Clearstead Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$18.86 - $23.55 $4,300 - $5,369	228 New	228 $4,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $12,234 - $18,234	-339 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $12,075 - $17,956	339 New	339 $16,000
Q4 2020 Feb 11, 2021	SELL	$32.49 - $61.88 $12,996 - $24,752	-400 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $10,692 - $14,268	400 New	400 $13,000

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearstead Advisors, LLC with notifications on news.